A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were randomised to receive either sequential therapy with three cycles of ifosfamide followed by three cycles of carboplatin, or to six cycles of single a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Perren, T. J., Wiltshaw, E., Harper, P., Slevin, M., Stein, R., Tan, S., Gore, M., Fryatt, I. J., Blake, P. R.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1993
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968655/
https://ncbi.nlm.nih.gov/pubmed/8260372
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars